Asthma inhaler tested to tame dangerous side effect of cancer treatment
NCT ID NCT06860542
Summary
This study is testing if using an inhaled steroid (like those for asthma) for one year can help prevent lung inflammation from coming back in cancer patients. The inflammation is a serious side effect of powerful immunotherapy drugs. The goal is to control this side effect with fewer of the strong medications that cause more problems, helping patients feel better and continue their cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED ADVERSE EVENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.